Parnax Lab Limited

BSE: 506128
Parnax Lab Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials and compliance.
CIN L36912MH1982PLC027925 Incorporated 03 August 1982 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Listed - BSE: 506128 Public Limited Company pharma
Data last updated
Revenue · FY 2026
₹248.54 Cr
▲ 32.39% YoY
Computed EBITDA · FY 2026
₹31.03 Cr
▲ 9.1% YoY
Net profit · FY 2026
₹11.8 Cr
▲ 2.25% YoY
Authorised capital
₹13 Cr
Registered with MCA
Paid-up capital
₹11.49 Cr
Issued & subscribed
Open charges
₹24.2 Cr
Satisfied ₹4.66 Cr
Company age
44 yrs
Est. 1982
Last financials
Mar 2025
Balance sheet date

About Parnax Lab Limited

Data last updated: 14 July 2026

Parnax Lab Limited is a public limited company based in Mumbai, Maharashtra, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 03 August 1982, the company has been in operation for over 44 years.

Registered with ROC Mumbai under CIN L36912MH1982PLC027925. Listed on BSE: 506128.

Capital: an authorised share capital of ₹13 Cr and a paid-up capital of ₹11.49 Cr. Formerly known as Krishna-Deep Trade and Investment Ltd. It is led by directors including Ami Mihir Shah and Yogesh Kantilal Varia.

Last AGM: 29 September 2025. Financial statements filed for year ended 31 March 2025. Office: Gala No. 114 Bldg. No. 8 Jogani Industrial Complex Chunabhatti, Mumbai, Maharashtra, India – 400022.

As per BSE-filed consolidated financials for FY 2026, the company reported a revenue of ₹248.54 Cr, a growth of 32.39% compared to the previous year. The net worth stands at ₹95.3 Cr (up 14.49% YoY). Total assets are valued at ₹227.63 Cr (up 19.92% YoY).

Its group structure includes 1 subsidiary.

The company is associated with 1 brand - Naxpar Group. As per MCA filings, the company has open charges of ₹24.2 Cr and satisfied charges of ₹4.66 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website naxparlab.com.

Company Details of Parnax Lab Limited
CIN L36912MH1982PLC027925
Registration Number 027925
Incorporation Date 03 August 1982
ROC Mumbai
Listing Status Listed (BSE: 506128)
Company Status Active
Date of Last AGM 29 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Key People
Mihir Prakash Shah Managing Director Ami Mihir Shah Director Yogesh Kantilal Varia Director
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    naxparlab.com
  • Social Media
    Locked
  • Registered Address
    Gala No. 114 Bldg. No. 8 Jogani Industrial Complex Chunabhatti, Mumbai, Maharashtra, India – 400022
  • Industry
    Pharma, Drug Formulation & Development
Company report
Parnax Lab Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Parnax Lab Limited report

Financials, compliance, directors, charges, ownership and filings for Parnax Lab Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Parnax Lab Limited

Parnax Lab Limited has one previous CIN (Corporate Identification Number): L67120MH1982PLC027925. The current CIN is L36912MH1982PLC027925, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
L36912MH1982PLC027925 Current
L67120MH1982PLC027925 Previous

Associated Brands with Parnax Lab Limited

Parnax Lab Limited operates one associated brand: Naxpar Group. These brands represent Parnax Lab Limited's diversified market presence and brand portfolio.

Brand Description Website
Naxpar Group
Pharmaceutical, cosmetic, herbal, and nutraceutical formulations are manufactured. naxparlab.com

Business Activity of Parnax Lab Limited

Parnax Lab Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products Locked
Premium access

Business activity turnover details for Parnax Lab Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Parnax Lab Limited

Parnax Lab Limited is audited by M/s C N Patel & Co. (ICAI peer reviewed, certificate valid till 2027-05-31) for the financial year 2026, as reported in its BSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.

Name Financial year Audit opinion
M/s C N Patel & Co. (ICAI peer reviewed, certificate valid till 2027-05-31) FY 2026 Declaration of unmodified opinion

Board of Directors of Parnax Lab Limited

Parnax Lab Limited is currently managed by 6 directors, with 15 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Ami Mihir Shah
Also directs: Naxpar Medicamentos Llp, Naxpar Health Concepts Private Limited, Naxpar Int Llp
Director 31 Mar 2015 11 Years 4 Months Current
Yogesh Kantilal Varia
Also directs: Naxpar Pharma Private Limited
Director 28 May 2021 5 Years 2 Months Current
Vijaykumar Shivaji Ayare
Also directs: Wanbury Pharma Limited
Director 10 Feb 2025 1 Years 6 Months Current
Mihir Prakash Shah
Also directs: Novomed Pharma Pvt. Ltd, Naxpar Pharma Private Limited
Managing Director 05 Jul 2024 2 Years 1 Months Current
Binoy Baiju Shah
Also directs: Novomed Pharma Pvt. Ltd, Naxpar Medicamentos Llp, Naxpar Health Concepts Private Limited
Director 05 Jul 2024 2 Years 1 Months Current
Harish Sunderlal Panpalia
Also directs: Naxpar Pharma Private Limited
Director 11 Aug 2023 3 Years 0 Months Current
View all directors

Financials of Parnax Lab Limited FY 2026 filings available

Parnax Lab Limited reported revenue of ₹248.54 Cr (up 32.39% YoY) for FY 2026.

Revenue · FY 2026
₹248.54 Cr ▲ 32.39%
Profit · FY 2026
₹11.8 Cr ▲ 2.25%
Computed EBITDA · FY 2026
₹31.03 Cr ▲ 9.1%
Revenue₹ Cr · Consolidated0100200300FY 2019: ₹109 Cr109FY 2019FY 2020: ₹95 Cr · -12.4% YoY95.3-12.4%FY 2020FY 2021: ₹90 Cr · -6.1% YoY89.5-6.1%FY 2021FY 2022: ₹163 Cr · +82.1% YoY163+82.1%FY 2022FY 2023: ₹168 Cr · +2.8% YoY168+2.8%FY 2023FY 2024: ₹189 Cr · +12.6% YoY189+12.6%FY 2024FY 2025: ₹188 Cr · -0.5% YoY188-0.5%FY 2025FY 2026: ₹249 Cr · +32.4% YoY249+32.4%FY 2026
Net Profit₹ Cr · Consolidated-5051015FY 2019: ₹3 Cr3.3FY 2019FY 2020: ₹3 Cr (loss) · -188.2% YoY-2.9FY 2020FY 2021: ₹0 Cr (loss) · +87.6% YoY-0.4FY 2021FY 2022: ₹8 Cr · +2389.5% YoY8.3+2389.5%FY 2022FY 2023: ₹9 Cr · +4.5% YoY8.6+4.5%FY 2023FY 2024: ₹9 Cr · +7.7% YoY9.3+7.7%FY 2024FY 2025: ₹12 Cr · +24.2% YoY11.5+24.2%FY 2025FY 2026: ₹12 Cr · +2.2% YoY11.8+2.2%FY 2026
Quarterly Revenue₹ Cr · vs same quarter last year0255075Q1'25: ₹50 Cr50.1Q1'25Q2'25: ₹48 Cr48.4Q2'25Q3'25: ₹40 Cr40.2Q3'25Q4'25: ₹49 Cr49Q4'25Q1'26: ₹53 Cr · +6.5% YoY53.4+6.5%Q1'26Q2'26: ₹63 Cr · +29.4% YoY62.6+29.4%Q2'26Q3'26: ₹63 Cr · +56.5% YoY62.9+56.5%Q3'26Q4'26: ₹70 Cr · +42% YoY69.6+42%Q4'26
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Revenue from Operations ₹248.54 Cr ₹187.74 Cr ₹188.71 Cr ₹167.61 Cr ₹163.03 Cr ₹89.52 Cr ₹95.31 Cr ₹108.78 Cr
Other Income ₹3.78 Cr ₹1.68 Cr ₹81.57 Lakh ₹77.22 Lakh ₹32.97 Lakh ₹21.03 Lakh ₹66.23 Lakh ₹2.11 Cr
Total Income ₹252.33 Cr ₹189.41 Cr ₹189.53 Cr ₹168.38 Cr ₹163.36 Cr ₹89.73 Cr ₹95.98 Cr ₹110.89 Cr
Cost of Materials Consumed ₹148.74 Cr ₹93.85 Cr ₹104.74 Cr ₹88.41 Cr ₹91.13 Cr ₹40.41 Cr ₹45.3 Cr ₹43.92 Cr
Purchases of Stock-in-Trade ₹33.7 Lakh ₹46.42 Lakh ₹15.02 Lakh ₹93.88 Lakh ₹17.11 Lakh ₹36.28 Lakh ₹87.97 Lakh ₹9.02 Cr
Changes in Inventories -₹1.99 Cr ₹1.69 Cr -₹2.07 Cr -₹53.37 Lakh -₹1.66 Cr ₹44.75 Lakh -₹90.34 Lakh -₹22.08 Lakh
Employee Benefit Expense ₹27.13 Cr ₹24.43 Cr ₹23.72 Cr ₹20.05 Cr ₹17.43 Cr ₹13.68 Cr ₹14.08 Cr ₹13.06 Cr
Finance Costs ₹5.71 Cr ₹5.39 Cr ₹5.35 Cr ₹4.95 Cr ₹5.23 Cr ₹5.08 Cr ₹4.6 Cr ₹3.89 Cr
Depreciation & Amortisation ₹8.05 Cr ₹7.38 Cr ₹6.96 Cr ₹6.53 Cr ₹5.87 Cr ₹5.16 Cr ₹4.46 Cr ₹3.82 Cr
Other Expenses ₹47.07 Cr ₹40.54 Cr ₹38.63 Cr ₹35.75 Cr ₹32.93 Cr ₹24.67 Cr ₹29.53 Cr ₹32.78 Cr
Total Expenses ₹235.05 Cr ₹173.74 Cr ₹177.48 Cr ₹156.1 Cr ₹151.1 Cr ₹89.81 Cr ₹97.94 Cr ₹106.27 Cr
Profit Before Exceptional Items & Tax ₹17.28 Cr ₹15.67 Cr ₹12.05 Cr ₹12.28 Cr ₹12.26 Cr -₹8.38 Lakh -₹1.97 Cr ₹4.62 Cr
Exceptional Items -₹1.37 Cr ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹15.91 Cr ₹15.67 Cr ₹12.05 Cr ₹12.28 Cr ₹12.26 Cr -₹8.38 Lakh -₹1.97 Cr ₹4.62 Cr
Total Tax Expense ₹4.11 Cr ₹4.13 Cr ₹2.76 Cr ₹3.84 Cr ₹4.01 Cr ₹27.69 Lakh ₹94.88 Lakh ₹1.31 Cr
Net Profit ₹11.8 Cr ₹11.54 Cr ₹9.29 Cr ₹8.63 Cr ₹8.26 Cr -₹36.07 Lakh -₹2.92 Cr ₹3.31 Cr
  attributable to Owners ₹11.78 Cr ₹11.52 Cr ₹9.61 Cr ₹8.62 Cr ₹8.24 Cr -₹36.22 Lakh -₹2.91 Cr ₹3.3 Cr
  attributable to NCI ₹2.18 Lakh ₹2.03 Lakh ₹1.56 Lakh ₹1.49 Lakh ₹1.54 Lakh ₹15,000 -₹18,000 ₹66,000
Other Comprehensive Income ₹25.96 Lakh ₹76,000 -₹19.1 Lakh -₹10.14 Lakh -₹11.57 Lakh ₹11.28 Lakh -₹2.12 Lakh -₹8 Lakh
Total Comprehensive Income ₹12.06 Cr ₹11.55 Cr ₹9.1 Cr ₹8.53 Cr ₹8.14 Cr -₹24.79 Lakh -₹2.94 Cr ₹3.23 Cr
EBITDA (computed) ₹31.03 Cr ₹28.44 Cr ₹24.36 Cr ₹23.76 Cr ₹23.36 Cr ₹10.16 Cr ₹7.09 Cr ₹12.33 Cr
Basic EPS ₹10.27 ₹10.05 ₹8.38 ₹7.80 ₹9.70 ₹-0.42 ₹-3.43 ₹3.89
Diluted EPS ₹10.27 ₹10.05 ₹8.38 ₹7.80 ₹9.70 ₹-0.42 ₹-3.43 ₹3.89
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Total Assets ₹227.63 Cr ₹189.82 Cr ₹188.77 Cr ₹145.07 Cr ₹154.09 Cr ₹106.26 Cr ₹107.14 Cr ₹94.68 Cr
Non-current Assets ₹134.59 Cr ₹121.48 Cr ₹113.33 Cr ₹84.01 Cr ₹78.7 Cr ₹67.02 Cr ₹61.53 Cr ₹57.79 Cr
Current Assets ₹90.69 Cr ₹64.78 Cr ₹71.81 Cr ₹57.32 Cr ₹71.65 Cr ₹35.5 Cr ₹41.87 Cr ₹33.17 Cr
Property, Plant & Equipment ₹114.05 Cr ₹108.64 Cr ₹79.39 Cr ₹72.86 Cr ₹71.86 Cr ₹59.52 Cr ₹57.47 Cr ₹50.78 Cr
Inventories ₹36.22 Cr ₹25.77 Cr ₹29.93 Cr ₹21.69 Cr ₹19.93 Cr ₹10.79 Cr ₹11.15 Cr ₹8.47 Cr
Trade Receivables ₹37.81 Cr ₹30.76 Cr ₹32.56 Cr ₹27.89 Cr ₹38.7 Cr ₹16.71 Cr ₹23.08 Cr ₹19.18 Cr
Cash & Equivalents ₹33.64 Lakh ₹54.99 Lakh ₹45.78 Lakh ₹1.28 Cr ₹4.36 Cr ₹18.14 Lakh ₹38.68 Lakh -₹5.19 Lakh
Equity (Net Worth) ₹95.3 Cr ₹83.24 Cr ₹71.69 Cr ₹62.26 Cr ₹48.28 Cr ₹32.62 Cr ₹32.87 Cr ₹35.81 Cr
Equity Share Capital ₹11.49 Cr ₹11.49 Cr ₹11.49 Cr ₹11.49 Cr ₹9.81 Cr ₹8.5 Cr ₹8.5 Cr ₹8.5 Cr
Borrowings (Non-current) ₹21.73 Cr ₹17.99 Cr ₹21.05 Cr ₹12.02 Cr ₹17.41 Cr ₹13.98 Cr ₹19.15 Cr ₹21.58 Cr
Borrowings (Current) ₹52.8 Cr ₹42.65 Cr ₹50.01 Cr ₹38.88 Cr ₹48.06 Cr ₹36.43 Cr ₹28.11 Cr ₹15.69 Cr
Total Debt (computed) ₹74.52 Cr ₹60.64 Cr ₹71.06 Cr ₹50.9 Cr ₹65.47 Cr ₹50.41 Cr ₹47.27 Cr ₹37.27 Cr
Current Liabilities ₹95.85 Cr ₹74.33 Cr ₹81.83 Cr ₹63.04 Cr ₹81.61 Cr ₹54.37 Cr ₹52.42 Cr ₹36.29 Cr
Total Liabilities ₹132.33 Cr ₹106.58 Cr ₹117.07 Cr ₹82.81 Cr ₹105.81 Cr ₹73.64 Cr ₹74.27 Cr ₹58.87 Cr
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow ₹8 Cr ₹32.3 Cr ₹15.88 Cr ₹20.91 Cr ₹8.55 Cr
Investing Cash Flow -₹16.39 Cr -₹16.39 Cr -₹31.52 Cr -₹9.92 Cr -₹16.5 Cr
Financing Cash Flow ₹8.18 Cr -₹15.82 Cr ₹14.82 Cr -₹14.07 Cr ₹12.13 Cr
Capital Expenditure ₹17.31 Cr ₹18.58 Cr ₹32.42 Cr ₹10.27 Cr ₹16.26 Cr
Free Cash Flow (computed) -₹9.31 Cr ₹13.72 Cr -₹16.54 Cr ₹10.64 Cr -₹7.71 Cr
Dividends Paid ₹0 ₹0 ₹0 ₹0 ₹0
Net Change in Cash -₹21.35 Lakh ₹9.21 Lakh -₹82.18 Lakh -₹3.08 Cr ₹4.18 Cr
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25
Revenue from Operations ₹69.63 Cr ₹62.94 Cr ₹62.6 Cr ₹53.38 Cr ₹49.04 Cr ₹40.22 Cr ₹48.36 Cr ₹50.12 Cr
Other Income ₹1.99 Cr ₹97.15 Lakh ₹63.13 Lakh ₹18.46 Lakh ₹42.57 Lakh ₹18.95 Lakh ₹94.95 Lakh ₹11.18 Lakh
Total Income ₹71.62 Cr ₹63.91 Cr ₹63.23 Cr ₹53.56 Cr ₹49.46 Cr ₹40.41 Cr ₹49.31 Cr ₹50.23 Cr
Cost of Materials Consumed ₹43.76 Cr ₹37.86 Cr ₹34.82 Cr ₹32.27 Cr ₹25.74 Cr ₹23.29 Cr ₹21.52 Cr ₹23.31 Cr
Purchases of Stock-in-Trade ₹0 ₹4.48 Lakh ₹0 ₹33.25 Lakh ₹38.5 Lakh ₹6.76 Lakh ₹13.61 Lakh ₹36.83 Lakh
Changes in Inventories -₹30.66 Lakh -₹56.78 Lakh ₹1.5 Cr -₹2.62 Cr ₹16.11 Lakh -₹1.79 Cr ₹3 Cr -₹17.29 Lakh
Employee Benefit Expense ₹7.2 Cr ₹7.1 Cr ₹6.44 Cr ₹6.39 Cr ₹6.22 Cr ₹5.67 Cr ₹6.12 Cr ₹6.42 Cr
Finance Costs ₹1.61 Cr ₹1.47 Cr ₹1.4 Cr ₹1.22 Cr ₹1.28 Cr ₹1.23 Cr ₹1.38 Cr ₹1.5 Cr
Depreciation & Amortisation ₹2.04 Cr ₹1.96 Cr ₹2.1 Cr ₹1.94 Cr ₹1.83 Cr ₹1.79 Cr ₹1.94 Cr ₹1.83 Cr
Other Expenses ₹14.09 Cr ₹11.66 Cr ₹11.76 Cr ₹9.57 Cr ₹9.91 Cr ₹8.71 Cr ₹10.34 Cr ₹11.58 Cr
Total Expenses ₹68.39 Cr ₹59.52 Cr ₹58.03 Cr ₹49.11 Cr ₹45.51 Cr ₹38.96 Cr ₹44.44 Cr ₹44.83 Cr
Profit Before Exceptional Items & Tax ₹3.23 Cr ₹4.39 Cr ₹5.2 Cr ₹4.46 Cr ₹3.95 Cr ₹1.45 Cr ₹4.87 Cr ₹5.4 Cr
Exceptional Items -₹23.13 Lakh -₹1.14 Cr ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹3 Cr ₹3.25 Cr ₹5.2 Cr ₹4.46 Cr ₹3.95 Cr ₹1.45 Cr ₹4.87 Cr ₹5.4 Cr
Total Tax Expense ₹81.38 Lakh ₹53.29 Lakh ₹1.58 Cr ₹1.18 Cr ₹1.03 Cr ₹23.5 Lakh ₹1.46 Cr ₹1.42 Cr
Net Profit ₹2.18 Cr ₹2.72 Cr ₹3.62 Cr ₹3.27 Cr ₹2.93 Cr ₹1.21 Cr ₹3.41 Cr ₹3.99 Cr
  attributable to Owners ₹2.18 Cr ₹2.71 Cr ₹3.62 Cr ₹3.27 Cr ₹2.92 Cr ₹1.21 Cr ₹3.41 Cr ₹3.98 Cr
  attributable to NCI ₹54,000 ₹39,000 ₹63,000 ₹61,000 ₹60,000 ₹21,000 ₹63,000 ₹59,000
Other Comprehensive Income ₹7.36 Lakh ₹18.6 Lakh ₹0 ₹0 ₹76,000 ₹0 ₹0 ₹0
Total Comprehensive Income ₹2.26 Cr ₹2.9 Cr ₹3.62 Cr ₹3.27 Cr ₹2.93 Cr ₹1.21 Cr ₹3.41 Cr ₹3.99 Cr
EBITDA (computed) ₹6.88 Cr ₹7.82 Cr ₹8.71 Cr ₹7.62 Cr ₹7.06 Cr ₹4.46 Cr ₹8.19 Cr ₹8.73 Cr
Basic EPS ₹1.90 ₹2.37 ₹3.15 ₹2.85 ₹2.55 ₹1.06 ₹2.97 ₹3.47
Diluted EPS ₹1.90 ₹2.37 ₹3.15 ₹2.85 ₹2.55 ₹1.06 ₹2.97 ₹3.47
Latest 8 quarters shown.
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Revenue from Operations ₹6.63 Cr ₹7.02 Cr ₹7.44 Cr ₹7.47 Cr ₹7.15 Cr ₹2.37 Cr ₹7.68 Cr ₹6.49 Cr
Other Income ₹2.37 Cr ₹70.95 Lakh ₹53.5 Lakh ₹37.08 Lakh ₹16.16 Lakh ₹6.51 Lakh ₹41.58 Lakh ₹51.21 Lakh
Total Income ₹8.99 Cr ₹7.73 Cr ₹7.98 Cr ₹7.84 Cr ₹7.31 Cr ₹2.44 Cr ₹8.1 Cr ₹7 Cr
Cost of Materials Consumed ₹1.32 Cr ₹1.1 Cr ₹2.32 Cr ₹1.65 Cr ₹1.9 Cr ₹28.39 Lakh ₹2.61 Cr ₹2.35 Cr
Purchases of Stock-in-Trade ₹1.46 Cr ₹1.77 Cr ₹68.34 Lakh ₹1.83 Cr ₹1.48 Cr ₹1.17 Cr ₹1.71 Cr ₹83.09 Lakh
Changes in Inventories ₹26.13 Lakh ₹13.25 Lakh ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Employee Benefit Expense ₹93.71 Lakh ₹90.2 Lakh ₹73.64 Lakh ₹55.21 Lakh ₹51.78 Lakh ₹44.72 Lakh ₹51.34 Lakh ₹45.09 Lakh
Finance Costs ₹3.31 Lakh ₹2.39 Lakh ₹14.1 Lakh ₹24.9 Lakh ₹70.54 Lakh ₹83 Lakh ₹1.38 Cr ₹1.08 Cr
Depreciation & Amortisation ₹6.48 Lakh ₹6.34 Lakh ₹5.83 Lakh ₹6.78 Lakh ₹4.47 Lakh ₹4.4 Lakh ₹4.38 Lakh ₹4.84 Lakh
Other Expenses ₹4.23 Cr ₹1.88 Cr ₹1.59 Cr ₹1.87 Cr ₹1.88 Cr ₹91.22 Lakh ₹2.32 Cr ₹2.75 Cr
Total Expenses ₹8.31 Cr ₹5.87 Cr ₹5.53 Cr ₹6.22 Cr ₹6.53 Cr ₹3.69 Cr ₹8.57 Cr ₹7.51 Cr
Profit Before Exceptional Items & Tax ₹68.19 Lakh ₹1.86 Cr ₹2.45 Cr ₹1.63 Cr ₹77.98 Lakh -₹1.25 Cr -₹47.2 Lakh -₹50.84 Lakh
Exceptional Items -₹3.49 Lakh ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹64.7 Lakh ₹1.86 Cr ₹2.45 Cr ₹1.63 Cr ₹77.98 Lakh -₹1.25 Cr -₹47.2 Lakh -₹50.84 Lakh
Total Tax Expense -₹24.05 Lakh ₹46.35 Lakh ₹62.34 Lakh ₹42.23 Lakh ₹23.83 Lakh -₹12.31 Lakh ₹1.53 Cr ₹31.9 Lakh
Net Profit ₹88.75 Lakh ₹1.39 Cr ₹1.82 Cr ₹1.2 Cr ₹54.15 Lakh -₹1.13 Cr -₹2 Cr -₹82.74 Lakh
Other Comprehensive Income -₹98,000 -₹53,000 -₹2.42 Lakh -₹5.08 Lakh -₹2.14 Lakh ₹2.29 Lakh ₹33,000 -₹2,000
Total Comprehensive Income ₹87.77 Lakh ₹1.39 Cr ₹1.8 Cr ₹1.15 Cr ₹52.01 Lakh -₹1.11 Cr -₹2 Cr -₹82.76 Lakh
EBITDA (computed) ₹77.98 Lakh ₹1.95 Cr ₹2.65 Cr ₹1.94 Cr ₹1.53 Cr -₹37.96 Lakh ₹95.03 Lakh ₹61.96 Lakh
Basic EPS ₹0.77 ₹1.21 ₹1.59 ₹1.09 ₹0.64 ₹-1.33 ₹-2.36 ₹-0.97
Diluted EPS ₹0.77 ₹1.21 ₹1.59 ₹1.09 ₹0.64 ₹-1.33 ₹-2.36 ₹-0.97
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Total Assets ₹24.6 Cr ₹24.72 Cr ₹22.24 Cr ₹21.37 Cr ₹23.53 Cr ₹17.64 Cr ₹18.65 Cr ₹20.41 Cr
Non-current Assets ₹10.42 Cr ₹10.46 Cr ₹10.58 Cr ₹11.13 Cr ₹11.64 Cr ₹11.95 Cr ₹11.71 Cr ₹13.29 Cr
Current Assets ₹11.82 Cr ₹10.69 Cr ₹8.04 Cr ₹6.5 Cr ₹8.16 Cr ₹1.95 Cr ₹3.2 Cr ₹3.39 Cr
Property, Plant & Equipment ₹39.13 Lakh ₹42.51 Lakh ₹48.77 Lakh ₹42.53 Lakh ₹44.16 Lakh ₹48.63 Lakh ₹53.02 Lakh ₹57.22 Lakh
Inventories ₹80.17 Lakh ₹78.3 Lakh ₹90.11 Lakh ₹57.57 Lakh ₹79.49 Lakh ₹57.98 Lakh ₹15.05 Lakh ₹41.77 Lakh
Trade Receivables ₹41.86 Lakh ₹84.52 Lakh ₹59.44 Lakh ₹1.08 Cr ₹1.86 Cr ₹43.26 Lakh ₹2.06 Cr ₹2.5 Cr
Cash & Equivalents ₹32.15 Lakh ₹50.34 Lakh ₹43.97 Lakh ₹1.27 Cr ₹4.33 Cr ₹10.17 Lakh ₹10.79 Lakh -₹52.99 Lakh
Equity (Net Worth) ₹23.42 Cr ₹22.54 Cr ₹21.15 Cr ₹19.35 Cr ₹12.75 Cr ₹4.71 Cr ₹5.82 Cr ₹7.82 Cr
Equity Share Capital ₹11.49 Cr ₹11.49 Cr ₹11.49 Cr ₹11.49 Cr ₹9.81 Cr ₹8.5 Cr ₹8.5 Cr ₹8.5 Cr
Borrowings (Non-current) ₹16.28 Lakh ₹40.66 Lakh ₹0 ₹16.08 Lakh ₹1.15 Cr ₹1.89 Cr ₹2.77 Cr ₹8.33 Cr
Borrowings (Current) ₹0 ₹0 ₹0 ₹91.07 Lakh ₹8.05 Cr ₹8.78 Cr ₹8.03 Cr ₹2.27 Cr
Total Debt (computed) ₹16.28 Lakh ₹40.66 Lakh ₹0 ₹1.07 Cr ₹9.2 Cr ₹10.67 Cr ₹10.8 Cr ₹10.6 Cr
Current Liabilities ₹99.61 Lakh ₹1.74 Cr ₹1.06 Cr ₹1.84 Cr ₹9.63 Cr ₹11.03 Cr ₹10.04 Cr ₹4.24 Cr
Total Liabilities ₹1.18 Cr ₹2.17 Cr ₹1.08 Cr ₹2.01 Cr ₹10.78 Cr ₹12.93 Cr ₹12.83 Cr ₹12.58 Cr
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow -₹72.05 Lakh ₹27.91 Lakh ₹8.36 Lakh -₹28.16 Lakh -₹36.02 Lakh
Investing Cash Flow ₹57.16 Lakh -₹19.15 Lakh ₹30.21 Lakh ₹13.77 Lakh ₹0
Financing Cash Flow -₹3.3 Lakh -₹2.39 Lakh -₹1.21 Cr -₹2.92 Cr ₹4.59 Cr
Capital Expenditure ₹3.1 Lakh ₹0 ₹12.06 Lakh ₹5.19 Lakh ₹0
Free Cash Flow (computed) -₹75.15 Lakh ₹27.91 Lakh -₹3.7 Lakh -₹33.35 Lakh -₹36.02 Lakh
Dividends Paid ₹0 ₹0 ₹0 ₹0 ₹0
Net Change in Cash -₹18.19 Lakh ₹6.37 Lakh -₹82.67 Lakh -₹3.07 Cr ₹4.23 Cr
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25
Revenue from Operations ₹24.83 Lakh ₹2.71 Cr ₹1.7 Cr ₹1.97 Cr ₹83.7 Lakh ₹98.63 Lakh ₹1.54 Cr ₹3.66 Cr
Other Income ₹1.76 Cr ₹21.97 Lakh ₹19.67 Lakh ₹18.69 Lakh ₹18.93 Lakh ₹16.67 Lakh ₹18.07 Lakh ₹17.28 Lakh
Total Income ₹2.01 Cr ₹2.93 Cr ₹1.9 Cr ₹2.15 Cr ₹1.03 Cr ₹1.15 Cr ₹1.72 Cr ₹3.83 Cr
Cost of Materials Consumed ₹17.83 Lakh ₹51.22 Lakh ₹46.36 Lakh ₹17.05 Lakh ₹40,000 ₹36.67 Lakh ₹50.67 Lakh ₹22.09 Lakh
Purchases of Stock-in-Trade ₹0 ₹25.93 Lakh ₹23.77 Lakh ₹96 Lakh ₹90.09 Lakh ₹6.77 Lakh ₹18.38 Lakh ₹1.11 Cr
Changes in Inventories -₹6.72 Lakh ₹20.59 Lakh -₹10.18 Lakh ₹22.45 Lakh -₹36.04 Lakh ₹0 ₹0 ₹0
Employee Benefit Expense ₹22.62 Lakh ₹27.76 Lakh ₹22.51 Lakh ₹20.82 Lakh ₹22.39 Lakh ₹25.27 Lakh ₹21.55 Lakh ₹20.99 Lakh
Finance Costs ₹61,000 ₹18,000 ₹1.54 Lakh ₹98,000 ₹50,000 ₹97,000 ₹20,000 ₹72,000
Depreciation & Amortisation ₹1.6 Lakh ₹1.63 Lakh ₹1.67 Lakh ₹1.58 Lakh ₹1.57 Lakh ₹1.59 Lakh ₹1.6 Lakh ₹1.58 Lakh
Other Expenses ₹2.92 Cr ₹68.19 Lakh ₹37.96 Lakh ₹25.17 Lakh ₹34.91 Lakh ₹23.47 Lakh ₹43.11 Lakh ₹86.55 Lakh
Total Expenses ₹3.28 Cr ₹1.96 Cr ₹1.24 Cr ₹1.84 Cr ₹1.14 Cr ₹94.74 Lakh ₹1.36 Cr ₹2.43 Cr
Profit Before Exceptional Items & Tax -₹1.27 Cr ₹97.29 Lakh ₹66.15 Lakh ₹31.39 Lakh -₹11.19 Lakh ₹20.56 Lakh ₹36.14 Lakh ₹1.4 Cr
Exceptional Items -₹1.33 Lakh -₹2.16 Lakh ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax -₹1.28 Cr ₹95.13 Lakh ₹66.15 Lakh ₹31.39 Lakh -₹11.19 Lakh ₹20.56 Lakh ₹36.14 Lakh ₹1.4 Cr
Total Tax Expense -₹72.98 Lakh ₹24.22 Lakh ₹16.81 Lakh ₹7.9 Lakh -₹2.83 Lakh ₹4.78 Lakh ₹9.09 Lakh ₹35.31 Lakh
Net Profit -₹54.99 Lakh ₹70.91 Lakh ₹49.34 Lakh ₹23.49 Lakh -₹8.36 Lakh ₹15.78 Lakh ₹27.05 Lakh ₹1.05 Cr
Other Comprehensive Income ₹49,000 -₹1.47 Lakh ₹0 ₹0 -₹53,000 ₹0 ₹0 ₹0
Total Comprehensive Income -₹54.5 Lakh ₹69.44 Lakh ₹49.34 Lakh ₹23.49 Lakh -₹8.89 Lakh ₹15.78 Lakh ₹27.05 Lakh ₹1.05 Cr
EBITDA (computed) -₹1.24 Cr ₹99.1 Lakh ₹69.36 Lakh ₹33.95 Lakh -₹9.12 Lakh ₹23.12 Lakh ₹37.94 Lakh ₹1.43 Cr
Basic EPS ₹-0.48 ₹0.62 ₹0.43 ₹0.20 ₹-0.07 ₹0.14 ₹0.24 ₹0.91
Diluted EPS ₹-0.48 ₹0.62 ₹0.43 ₹0.20 ₹-0.07 ₹0.14 ₹0.24 ₹0.91
Latest 8 quarters shown.
Want more history and ratios?
You're viewing the latest exchange-filed financials for Parnax Lab Limited. The full report adds 10+ years of line-item history, 20+ ratios, peer benchmarks and a downloadable PDF.
10+ years of history 20+ ratios & benchmarks Downloadable PDF

Shareholding Pattern of Parnax Lab Limited

As per the shareholding pattern filed with BSE for the quarter ended Mar 2026, promoters hold 72.30%, retail and other public shareholders hold 27.70% of Parnax Lab Limited. The company had 3,721 shareholders on record.

Promoters: 72.30%Retail & Others: 27.70%
Mar 2026
QUARTER
72.30% Promoters
27.70% Retail & Others
Promoter holding - history
Now 72.30% · Mar 2026High 72.30% · Jun 2023Low 72.30% · Jun 2023
71%71.8%72.5%73.3%74%Jun 2023Dec 2023Jun 2024Dec 2024Jun 2025Dec 2025Jun 2023: 72.30%Sep 2023: 72.30%Dec 2023: 72.30%Mar 2024: 72.30%Jun 2024: 72.30%Sep 2024: 72.30%Dec 2024: 72.30%Mar 2025: 72.30%Jun 2025: 72.30%Sep 2025: 72.30%Dec 2025: 72.30%Mar 2026: 72.30%72.30%72.30%
Shareholding trend - last 6 quarters
Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Promoters72.30%72.30%72.30%72.30%72.30%72.30%
Public27.70%27.70%27.70%27.70%27.70%27.70%
Shareholding history - year on year (as at 31 March)
Mar 2026Mar 2025Mar 2024
Promoters72.30%72.30%72.30%
Public27.70%27.70%27.70%
Promoter change (YoY, %pts)+0.00+0.00-

Group Structure of Parnax Lab Limited

Parnax Lab Limited has 1 subsidiary company. This group structure data is as of FY 2023. The corporate group structure reflects Parnax Lab Limited's business expansion strategy and organizational complexity.

1
Subsidiary companies
Key Subsidiaries
Company Name CIN Shares Held
Naxpar Pharma Private Limited U52310MH2004PTC144449 -

Showing major subsidiaries. Total: 1.

Charges & Borrowings of Parnax Lab Limited

Open charges
₹24.2 Cr
Satisfied charges
₹4.66 Cr
Breakdown by lending institutions
State Bank of India₹24.20 Cr
Latest charge details
DateLenderAmountStatus
07 Sep 2002 State Bank of India ₹10.39 Cr Open
30 Mar 2000 State Bank of India ₹2.72 Cr Open
30 Mar 2000 State Bank of India ₹10.39 Cr Open
04 May 1995 State Bank of India ₹26 Lakh Open
04 May 1995 State Bank of India ₹26 Lakh Open

Total charge records: 9 View all charges

Employees and EPFO Compliance at Parnax Lab Limited

View historical data on people associated with Parnax Lab Limited, including employment history and EPFO contributions.

Premium access

Employee and EPFO history for Parnax Lab Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Parnax Lab Limited

Premium access

GST registrations and filing compliance for Parnax Lab Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Parnax Lab Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Parnax Lab Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Parnax Lab Limited

Premium access

MSME payment history for Parnax Lab Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Parnax Lab Limited

Premium access

Corporate group structure for Parnax Lab Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Parnax Lab Limited

Premium access

MCA filings and documents for Parnax Lab Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Parnax Lab Limited

Activity
29 Sep 2025
Parnax Lab Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records.
Activity
31 Mar 2025
Parnax Lab Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Directors
10 Feb 2025
Vijaykumar Shivaji Ayare was appointed as a Director on 10 Feb 2025 & has been associated with this company since 1 year 6 months.
Directors
03 Aug 2024
Mihir Prakash Shah was appointed as a Ceo on 03 Aug 2024 & has been associated with this company since 2 years 10 days.
Directors
03 Aug 2024
Binoy Baiju Shah was appointed as a Cfo on 03 Aug 2024 & has been associated with this company since 2 years 10 days.
Directors
05 Jul 2024
Mihir Prakash Shah was appointed as a Managing Director on 05 Jul 2024 & has been associated with this company since 2 years 1 month.

Recent News on Parnax Lab Limited

Frequently Asked Questions about Parnax Lab Limited

Parnax Lab Limited is an active public limited company in the pharma sector based in Mumbai, Maharashtra, India. It was incorporated on 03 August 1982 (44+ years old) and is registered under CIN L36912MH1982PLC027925. Listed on BSE: 506128.

Parnax Lab Limited reported revenue of ₹248.54 Cr for FY 2026 (up 32.39% YoY) based on consolidated BSE filings.

The current directors of Parnax Lab Limited are:

The primary industry of Parnax Lab Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Yes. Parnax Lab Limited is listed on BSE with code 506128.

Parnax Lab Limited can be reached at the registered office: Gala No. 114 Bldg. No. 8 Jogani Industrial Complex Chunabhatti, Mumbai, Maharashtra, India – 400022, or through the website naxparlab.com.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available